Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
05/2001
05/22/2001US6235778 Anticoagulants
05/22/2001US6235756 Methods and compositions for inhibition of angiogenesis by thalidomide
05/22/2001US6235680 N-acylsulfonamides, novel mixtures of herbicides and antidotes, and their use
05/17/2001WO2001034596A2 Pyrrolecarbonylimino derivatives as naaladase inhibitors
05/17/2001WO2001034594A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
05/17/2001WO2001034580A1 Heterocycle substituted diphenyl leukotriene antagonists
05/17/2001WO2001034567A1 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa
05/17/2001WO2001034558A1 Chemically modified supports and process for producing the same
05/17/2001WO2001034135A2 Oncolytic combinations for the treatment of cancer
05/17/2001CA2391230A1 Heterocycle substituted diphenyl leukotriene antagonists
05/17/2001CA2390789A1 Oncolytic combinations for the treatment of cancer
05/17/2001CA2390231A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
05/16/2001EP1099691A1 N-Sulfonyloxyimide compound and radiation-sensitive resin composition using the same
05/16/2001EP1098892A1 Biphenyl derivatives
05/16/2001EP1098877A1 Derivatized polymers of alpha-olefin-maleic anhydride alkyl half-ester or full acid
05/16/2001EP1098866A1 Method for producing ortho-alkylated benzoic acid derivatives
05/16/2001EP1098666A2 Water-soluble drugs and methods for their production
05/16/2001EP1039886A4 Hiv/fiv protease inhibitors having a small p3 residue
05/16/2001EP0769003B1 Amino acid-derived diaminopropanols
05/16/2001CN1295561A N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres
05/16/2001CN1295479A Beta 2-adrenergic receptor agonist
05/16/2001CN1295471A Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders
05/16/2001CN1295065A Phenyl heterocyclic compound used as epoxy enzyme -2 inhibitor
05/15/2001US6232476 Intermediates in a process for cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]ethyl}pyrrolidine
05/15/2001US6232475 Reacting a substituted bromobenzene with n-vinylimide; catalytic hydrogenation
05/15/2001US6232467 Biosynthesis of an amine with ketone and boron compound; compoundlibraries
05/15/2001US6232430 Cross-linkers for cross-linkable optical polycarbonates
05/15/2001US6232356 Reactive catalyst compositions for improving water blown polyurethane foam performance
05/15/2001US6232338 4-Mercaptopyrrolidine derivatives as farnesyl transferase inhibitors
05/15/2001US6232329 Tetrahydropyridine-(or 4-hydroxypiperidine) alkylazoles
05/15/2001US6232321 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
05/15/2001US6232258 Oxygenation catalyst and process for producing a ketone using the same
05/15/2001CA2238978C Retroviral protease inhibiting compounds
05/10/2001WO2001032618A1 Pyrrole derivatives as phosphodiesterase vii inhibitors
05/10/2001WO2001032604A1 Activators of soluble guanylate cyclase
05/10/2001WO2001032602A1 Diaryl-enynes
05/10/2001WO2001019908A3 Recovery of modifier compounds and polar organic compounds from a poly(arylene sulfide) recycle mixture
05/10/2001WO2000078714A3 Succinimides as paper sizing agents
05/10/2001DE19953025A1 Pyrrolderivate als Phosphodiesterase VII-Hemmer Pyrrole derivatives as phosphodiesterase VII inhibitor
05/10/2001CA2389773A1 Activators of soluble guanylate cyclase
05/10/2001CA2387660A1 Diaryl-enynes as glycine transport inhibitors
05/09/2001EP1097719A1 NEP inhibitors for the treatment of female sexual dysfunction
05/09/2001EP1097718A1 NPY antagonists for the treatment of female sexual dysfunction
05/09/2001EP1097707A1 Treatment of female sexual dysfunction
05/09/2001EP1097706A1 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction
05/09/2001EP1097382A2 Imidazoline receptor binding compounds
05/09/2001EP1097152A2 Synthesis of compounds useful in the manufacture of ketorolac
05/09/2001EP1097134A1 Arylpiperazine derivatives useful as uroselective alpha1-adrenoceptor blockers
05/09/2001EP1097128A1 Imidamide derivatives
05/09/2001EP1097117A2 Aryl vinyl ether derivatives and their use as herbicides
05/09/2001EP1096931A2 Use of (s) (-)-amisulpride for the manufacture of a medicament for the treatment of schizophrenia
05/09/2001CN1294577A 钾通道抑制剂 Potassium channel inhibitors
05/09/2001CN1294568A Fluorinating agent, process for producing same, and use thereof
05/09/2001CN1294125A Method for recovering N-vinyl-2-pyrrolidone
05/09/2001CN1065527C Guanidine derivatives, process for producing same and cosmetics contg. same
05/08/2001US6229020 Reacting n-succinimidyl and p-nitrophenyl cinnamate derivatives with physiologically active substance such as an amino acid; protecting amino or hydroxy groups for analysis of biological reactions by irradiation with light
05/08/2001US6228942 Dehydration to esterify or amidate surface of oxidized or aminated carbon powder or fiber suspended in solution containing a monomer or polymer having amine, hydroxy, and/or viny ether groups
05/08/2001US6228872 Neurotrophic diamide and carbamate agents
05/08/2001US6228847 Inhibitors of nucleoside metabolism
05/08/2001CA2324484A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2323464A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2323191A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2323183A1 Compounds for the treatment of female sexual dysfunction
05/03/2001WO2001030756A1 Benzamidine derivatives
05/03/2001WO2001030755A1 Process for the production of n-methyl pyrrolidone using gamma butyrolactone and mixed methylamines as starting materials
05/03/2001WO2001030745A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
05/03/2001WO2001010839A3 Multivalent substituted ketoamides and amides for treating hair loss
05/03/2001CA2388684A1 Process for the production of n-methyl pyrrolidone using gamma butyrolactone and mixed methylamines as starting materials
05/02/2001EP1095020A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
05/02/2001EP1095016A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
05/02/2001EP1095015A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators
05/02/2001EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
05/02/2001EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
05/02/2001EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
05/02/2001EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
05/02/2001EP0946097B1 Composition and use
05/02/2001CN1293666A Benzenesulfonamide-derivatives and their use as medicaments
05/02/2001CN1293189A Beta-halogamma-hydroxypyrrolidone and its synthesis process
05/01/2001US6225437 Useful as internal and external sizing agents for paper and paper products
05/01/2001US6225351 For therapy of asthma, arthritis, and sepsis bronchitis, chronic obstructive airways disease, psoriasis, allergic rhinitis, dermatitis, sepsis, septic shock, cachexia, acquire immuno deficiency syndrome (aids)
05/01/2001US6225341 For inhibiting neuraminidase; for therapy and prophylaxis of virus infection
05/01/2001US6224665 Process for the preparation of highly chromatic perylene pigments
05/01/2001CA2001265C Analogs of peptidase substrates
04/2001
04/26/2001WO2001028999A1 Process for the preparation of amorphous atorvastatin calcium
04/26/2001WO2001028998A1 N-substituted perfluoroalkylated pyrrolidines, process for making them and process for the addition of rf-iodide to an olefin
04/26/2001WO2001028997A2 Synthesis of 4-substituted pyrrole-2-carbaldehyde compounds
04/26/2001WO2001028996A2 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
04/26/2001WO2001028987A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity
04/26/2001WO2000055125A3 N-cyanomethyl amides as protease inhibitors
04/26/2001DE19860972A1 Verfahren zur Herstellung derivatisierter Polymere A process for preparing derivatized polymers
04/26/2001CA2388859A1 Inhibitors of neuraminidases
04/26/2001CA2384240A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity
04/25/2001EP1094061A1 Process for recovering N-Vinyl-2-Pyrrolidone
04/25/2001EP1093454A1 Chiral compounds and their use as doping agents in liquid crystals
04/25/2001EP0701568B1 New peptide derivatives
04/24/2001US6222043 Coupling 2-amido-thiazole derivative with 2-phenyl4-(protected)amino-butyric acid; deprotecting amino protecting group; acylating product with carboxylic acid containing carbocyclic or heterocyclic group; deprotecting
04/24/2001US6222032 Conducting the c-alkylation or n-alkylation reaction in the presence of a slightly nucleophilic strong base comprising a phosphorus compound
04/24/2001US6222013 Esterifying amino acid or peptide by mixing with alkanol and chlorosulfonic acid; alcohol reacts with chlorosulfonic acid to form a hydrosulfate which then reacts with amino acid or peptide for form corresponding ester
04/24/2001US6221881 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
04/24/2001US6221865 Inhibitors of protein farnesyltransferase and protein geranylgeranyltransferase.